Castle Biosciences Inc (NASDAQ:CSTL) price on Friday, March 21, rose 2.24% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $20.52.
A look at the stock’s price movement, the close in the last trading session was $20.07, moving within a range at $19.8 and $21.01. The beta value (5-Year monthly) was 0.977 while the PE ratio in trailing twelve months stood at 33.48. Turning to its 52-week performance, $35.84 and $16.97 were the 52-week high and 52-week low respectively. Overall, CSTL moved -21.53% over the past month.
Castle Biosciences Inc’s market cap currently stands at around $585.11 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Feb-26.
Turning to the stock’s technical picture we see that short term indicators suggest on average that CSTL is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 50% Sell category.
3 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 3 recommend CSTL as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
CSTL’s current price about -3.86% and -17.61% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 39.27, while 7-day volatility ratio is 4.72% and 6.35% in the 30-day chart. Further, Castle Biosciences Inc (CSTL) has a beta value of 1.11, and an average true range (ATR) of 1.23. Analysts have given the company’s stock an average 52-week price target of $39.5, forecast between a low of $36 and high of $45. Looking at the price targets, the low is -75.44% off current price level while to achieve the yearly target high, price needs to move -119.3%. Nonetheless, investors will most likely welcome a -92.5% jump to $39.5 which is the analysts’ median price.
If we refocus on Castle Biosciences Inc (NASDAQ:CSTL), historical trading data shows that trading volumes averaged 0.55 over the past 10 days and 446.97K over the past 3 months. The company’s latest data on shares outstanding shows there are 28.48 million shares.
The 3.04% of Castle Biosciences Inc’s shares are in the hands of company insiders while institutional holders own 97.20% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 1.85 million on 2025-02-28, giving us a short ratio of 4.57. The data shows that as of 2025-02-28 short interest in Castle Biosciences Inc (CSTL) stood at 668.0 of shares outstanding, with shares short rising to 1.71 million registered in 2025-01-31. Current price change has pushed the stock -23.00% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the CSTL stock continues to rise going into the next quarter.
